Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update

Sensus Healthcare, Inc. (NASDAQ:SRTS) saw a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 845,600 shares, a decrease of 28.3% from the February 13th total of 1,180,000 shares. Based on an average trading volume of 325,600 shares, the short-interest ratio is presently 2.6 days. Currently, 6.2% of the company’s stock are sold short.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on SRTS shares. HC Wainwright boosted their price target on shares of Sensus Healthcare from $11.00 to $12.00 and gave the stock a “buy” rating in a report on Monday, February 10th. Lake Street Capital decreased their price target on Sensus Healthcare from $18.00 to $13.00 and set a “buy” rating for the company in a research report on Tuesday, March 11th.

Hedge Funds Weigh In On Sensus Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the business. Squarepoint Ops LLC increased its position in Sensus Healthcare by 175.5% during the 4th quarter. Squarepoint Ops LLC now owns 85,677 shares of the company’s stock valued at $593,000 after purchasing an additional 54,576 shares during the period. Man Group plc boosted its holdings in shares of Sensus Healthcare by 34.0% during the 4th quarter. Man Group plc now owns 59,338 shares of the company’s stock valued at $411,000 after buying an additional 15,059 shares in the last quarter. OMERS ADMINISTRATION Corp purchased a new stake in shares of Sensus Healthcare in the 4th quarter worth about $381,000. Millennium Management LLC grew its position in shares of Sensus Healthcare by 256.6% in the 4th quarter. Millennium Management LLC now owns 85,329 shares of the company’s stock worth $590,000 after buying an additional 61,403 shares during the period. Finally, BNP Paribas Financial Markets bought a new position in shares of Sensus Healthcare in the 4th quarter worth about $47,000. Institutional investors own 25.30% of the company’s stock.

Sensus Healthcare Trading Up 1.9 %

Shares of Sensus Healthcare stock traded up $0.09 during trading on Monday, hitting $4.74. The stock had a trading volume of 21,072 shares, compared to its average volume of 344,450. The firm has a market cap of $78.19 million, a price-to-earnings ratio of 11.85 and a beta of 1.28. Sensus Healthcare has a 12 month low of $3.09 and a 12 month high of $9.33. The business’s 50-day moving average is $6.03 and its 200 day moving average is $6.65.

Sensus Healthcare (NASDAQ:SRTS) last issued its earnings results on Wednesday, February 5th. The company reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by ($0.01). Sensus Healthcare had a return on equity of 12.60% and a net margin of 15.90%. As a group, equities analysts expect that Sensus Healthcare will post 0.32 EPS for the current year.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.